This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
What Makes Blachem (BCPC) a New Strong Buy Stock
by Zacks Equity Research
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stock to Buy for February 22nd
by Zacks Equity Research
NVDA, APAM and BCPC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 22, 2024.
Has Balchem (BCPC) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Blachem (BCPC) and ELEMENTIS (ELMTY) have performed compared to their sector so far this year.
Here's What Could Help Blachem (BCPC) Maintain Its Recent Price Strength
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Blachem (BCPC) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
CE or BCPC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CE vs. BCPC: Which Stock Is the Better Value Option?
Blachem (BCPC) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -5.75% and 3.01%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Celanese (CE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Blachem (BCPC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Valvoline (VVV) Q1 Earnings Match Estimates
by Zacks Equity Research
Valvoline (VVV) delivered earnings and revenue surprises of 0% and 0.68%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
CE or BCPC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CE vs. BCPC: Which Stock Is the Better Value Option?
Blachem (BCPC) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -1.10% and 3.57%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MATV or BCPC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MATV vs. BCPC: Which Stock Is the Better Value Option?
Do Options Traders Know Something About Balchem (BCPC) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Balchem (BCPC) stock based on the movements in the options market lately.
Blachem (BCPC) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of 16.25% and 4.05%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) Lags Q1 Earnings Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -10.26% and 0.23%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 25th
by Zacks Equity Research
BCPC, ASMIY and BRDG have been added to the Zacks Rank #5 (Strong Sell) List on April 25, 2023.
Blachem (BCPC) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -26.67% and 4.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Quaker Chemical (KWR) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 13.93% and 6.56%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) Q3 Earnings Miss Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -14.29% and 1.36%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Quaker Chemical (KWR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 21.68% and 1.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Nutrien (NTR) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Nutrien (NTR) delivered earnings and revenue surprises of -35.97% and 9.18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Blachem (BCPC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bears are Losing Control Over Blachem (BCPC), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Blachem (BCPC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Will Blachem (BCPC) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Blachem (BCPC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.